Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05311488 · ClinicalTrials.gov registry record
Early Detection of Neuropathy in ATTRv
A clinical trial, sponsored by University of Pennsylvania.
- Completed
- Registry status
- 47
- Enrollment target
NCT05311488: Completed study, sponsored by University of Pennsylvania.
NCT05311488 is a clinical trial that has completed, run by University of Pennsylvania. The registered enrollment target is 47 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05311488 has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- 47 participants
- Enrollment target
Study Summary
The purpose of the study is to evaluate and compare different tools that are used to detect evidence of peripheral neuropathy in patients with TTRv.
Primary Outcome
Change in Serum neurofilament light chain concentration at 12 months
Interventions
- DIAGNOSTIC_TEST neurofilament light chain
- DIAGNOSTIC_TEST In-vivo Meissner Corpuscle imaging
- DIAGNOSTIC_TEST Nerve conduction study
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 47 participants |
| Start Date | 2022-02-14 |
| Est. Completion | 2026-02-14 |
What the finished NCT05311488 record still lists
NCT05311488 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 47 participants, a relatively small participant target.
The record links to 0 conditions, and to 3 interventions - of which neurofilament light chain is the first listed.
NCT05311488 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05311488 about?
NCT05311488 is a clinical study titled "Early Detection of Neuropathy in ATTRv". The purpose of the study is to evaluate and compare different tools that are used to detect evidence of peripheral neuropathy in patients with TTRv.
What is the current status of trial NCT05311488?
This trial is currently completed. The enrollment target is 47 participants. The study started on 2022-02-14. Estimated completion is 2026-02-14.
What interventions are being tested in trial NCT05311488?
The interventions under investigation include: neurofilament light chain (DIAGNOSTIC_TEST), In-vivo Meissner Corpuscle imaging (DIAGNOSTIC_TEST), Nerve conduction study (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05311488?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03313011 · 47 participants
The Neurobiology of Two Distinct Types of Progressive Apraxia of Speech
- NCT03467516 · 47 participants · Phase 2
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Metastatic Uveal Melanoma
- NCT03886662 · 47 participants · Phase 1
A Study of LB-100 in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS)
- NCT04013802 · 47 participants · Phase 1
TETRAVI Multivirus CTL for Treatment of EBV, CMV, Adenovirus, and BK Infections Post Allogeneic SCT.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI